Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication

Graciela Andrei, Andrea Lisco, Christophe Vanpouille, Andrea Introini, Emanuela Balestra, Joost Van Den Oord, Tomas Cihlar, Carlo Federico Perno, Robert Snoeck, Leonid Margolis, Jan Balzarini

Research output: Contribution to journalArticlepeer-review

Abstract

The HIV reverse-transcriptase inhibitor, tenofovir, was recently formulated into a vaginal gel for use as a microbicide. In human trials, a 1% tenofovir gel inhibited HIV sexual transmission by 39% and, surprisingly, herpes simplex virus-2 (HSV-2) transmission by 51%. We demonstrate that the concentration achieved intravaginally with a 1% tenofovir topical gel has direct antiherpetic activity. Tenofovir inhibits the replication of HSV clinical isolates in human embryonic fibroblasts, keratinocytes, and organotypic epithelial 3D rafts, decreases HSV replication in human lymphoid and cervicovaginal tissues ex vivo, and delays HSV-induced lesions and death in topically treated HSV-infected mice. The active tenofovir metabolite inhibits HSV DNA-polymerase and HIV reverse-transcriptase. To exert dual antiviral effects, tenofovir requires topical administration to achieve a drug concentration higher than systemic levels achieved by oral treatment. These findings indicate that a single topical treatment, like tenofovir, can inhibit the transmission of HIV and its copathogens.

Original languageEnglish
Pages (from-to)379-389
Number of pages11
JournalCell Host and Microbe
Volume10
Issue number4
DOIs
Publication statusPublished - Oct 4 2011

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Cancer Research
  • Molecular Biology

Fingerprint Dive into the research topics of 'Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication'. Together they form a unique fingerprint.

Cite this